The incidence of HOXA trans-deregulated T-ALL with identified fusion transcripts was 17% (39/235) distributed as follows: MLLT10 fusions in 20 patients (9%), KMT2A fusions in 11 patients (5%), SET fusions in 8 patients (3%). This evidence concerns the gene SET and acute lymphoblastic leukemia.